1
|
Secondary Breast Angiosarcoma and Paclitaxel-dependent Prolonged Disease Control: Report of Two Cases and Review of the Literature. TUMORI JOURNAL 2015; 101:e60-3. [DOI: 10.5301/tj.5000252] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/18/2014] [Indexed: 11/20/2022]
Abstract
Secondary breast angiosarcomas are a well-known entity generally characterized by a poor outcome, especially in patients with advanced disease. Among the drugs with demonstrated activity, taxane derivatives are one of the most effective histology-driven treatments against angiosarcomas. We report two cases of secondary breast angiosarcoma, both characterized by a very peculiar behavior towards paclitaxel. Both patients showed local recurrence of angiosarcoma after primary surgery, and they achieved complete remission following treatment with weekly paclitaxel. When a locoregional recurrence was observed as a result of a brief treatment interruption or a treatment delay, a new complete remission was rapidly achieved with the resumption of the drug, without evidence of any significant adverse effects.
Collapse
|
2
|
Armengot-Carbó M, Roca-Estellés M, Quecedo-Estébanez E, Gimeno-Carpio E. Angiosarcoma of the Skin After Breast Cancer Radiotherapy. ACTAS DERMO-SIFILIOGRAFICAS 2012. [DOI: 10.1016/j.adengl.2012.07.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
3
|
Armengot-Carbó M, Roca-Estellés MJ, Quecedo-Estébanez E, Gimeno-Carpio E. [Angiosarcoma of the skin after breast cancer radiotherapy]. ACTAS DERMO-SIFILIOGRAFICAS 2012; 103:557-9. [PMID: 22465258 DOI: 10.1016/j.ad.2011.10.014] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2011] [Revised: 09/29/2011] [Accepted: 10/09/2011] [Indexed: 10/28/2022] Open
|